epanolol has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ankier, SI; Cockshott, ID; Crome, P; Laher, MS; Rakhra, GS | 1 |
| Cockshott, ID | 1 |
1 trial(s) available for epanolol and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of epanolol (ICI 141,292) in healthy young volunteers and comparative data in elderly patients with angina and subjects with renal or hepatic impairment.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aging; Angina Pectoris; Benzeneacetamides; Female; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Liver Diseases; Male; Middle Aged; Propanolamines; Reference Values; Species Specificity | 1989 |
1 other study(ies) available for epanolol and Kidney Diseases
| Article | Year |
|---|---|
ICI 141,292 (epanolol)--pharmacokinetics after single and repeated oral administration in the elderly with moderate renal impairment.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Benzeneacetamides; Creatinine; Female; Half-Life; Humans; Kidney Diseases; Male; Propanolamines | 1990 |